Moreover, a significant decrease in the expression of NR2F1, the negative regulation of TXNIP expression, was reported by the Schwamborn group in hMBOs derived from PD patients carrying the LRRK2 p.Gly2019Ser mutation [75]. This evidence concerns the gene TXNIP and Parkinson disease.